Search Results

You are looking at 71 - 80 of 1,070 items for :

  • prostate cancer x
  • Refine by access: All content x
Clear All
Jennifer Munkley Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK

Search for other papers by Jennifer Munkley in
Google Scholar
PubMed
Close

actions of androgen steroid hormones ( Livermore et al . 2016 ). Androgens also play a critical role in the development and progression of prostate cancer, and androgen deprivation therapy (ADT) is usually the first-line treatment for metastatic disease

Free access
Philipp Y Maximov Department of Breast Medical Oncology, MD Anderson Cancer Centre, Houston, Texas, USA

Search for other papers by Philipp Y Maximov in
Google Scholar
PubMed
Close
,
Balkees Abderrahman Department of Breast Medical Oncology, MD Anderson Cancer Centre, Houston, Texas, USA

Search for other papers by Balkees Abderrahman in
Google Scholar
PubMed
Close
,
Ramona F Curpan Institute of Chemistry, Romanian Academy, Timisoara, Romania

Search for other papers by Ramona F Curpan in
Google Scholar
PubMed
Close
,
Yousef M Hawsawi Department of Genetics, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Search for other papers by Yousef M Hawsawi in
Google Scholar
PubMed
Close
,
Ping Fan Department of Breast Medical Oncology, MD Anderson Cancer Centre, Houston, Texas, USA

Search for other papers by Ping Fan in
Google Scholar
PubMed
Close
, and
V Craig Jordan Department of Breast Medical Oncology, MD Anderson Cancer Centre, Houston, Texas, USA

Search for other papers by V Craig Jordan in
Google Scholar
PubMed
Close

Introduction Despite advances in understanding the molecular biology of prostate and breast cancers, they are still the most frequently diagnosed cancers in men and women, in the United States. There is no completely effective preventative for

Open access
Ta-Chun Yuan
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Close
,
Suresh Veeramani
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Close
, and
Ming-Fong Lin
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
Close

decades ago, their functional roles in prostate, especially in prostate cancer (PCa) progression, have received attention only recently. In normal prostate, NE cells are apparently involved in regulating epithelial cell growth and differentiation in an

Free access
Zhigang Zhao Department of Urology of Minimally Invasive Surgery Center, the First Affiliated Hospital of Guangzhou Medical College, No. 1–3, Kangda Road, Guangzhou 510230, Guangdong Province, People's Republic of China

Search for other papers by Zhigang Zhao in
Google Scholar
PubMed
Close
and
Guohua Zeng Department of Urology of Minimally Invasive Surgery Center, the First Affiliated Hospital of Guangzhou Medical College, No. 1–3, Kangda Road, Guangzhou 510230, Guangdong Province, People's Republic of China

Search for other papers by Guohua Zeng in
Google Scholar
PubMed
Close

Introduction High-grade prostatic intraepithelial neoplasia (HGPIN) is currently accepted as a risk factor for the delayed progression to prostate cancer (PCa; Dovey et al . 2005 , Ayala & Ro 2007 , Chin et al . 2007 , Montironi et al . 2007

Free access
K S Kimbro Department of Hematology and Oncology, Emory School of Medicine, Winship Cancer Institute, 1365 Clifton Road, NE, Atlanta, Georgia 30322, USA

Search for other papers by K S Kimbro in
Google Scholar
PubMed
Close
and
J W Simons Department of Hematology and Oncology, Emory School of Medicine, Winship Cancer Institute, 1365 Clifton Road, NE, Atlanta, Georgia 30322, USA

Search for other papers by J W Simons in
Google Scholar
PubMed
Close

-inducible factor 1 (HIF-1) complex. HIF-1 is involved in the cancer biology of many endocrine tumors. This review will concentrate on endocrine oncology: HIF-1 in breast cancer and prostate cancer, specifically. New data on HIF-1 signaling and the potential for

Free access
Neil A Bhowmick Department of Medicine, Cedars-Sinai Cancer, Los Angeles
Department of Research, Greater Los Angeles Veterans Administration, Los Angeles, California, USA

Search for other papers by Neil A Bhowmick in
Google Scholar
PubMed
Close
,
Jillian Oft Department of Infectious Diseases, Cedars-Sinai Medical Center, Los Angeles, California

Search for other papers by Jillian Oft in
Google Scholar
PubMed
Close
,
Tanya Dorff Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California

Search for other papers by Tanya Dorff in
Google Scholar
PubMed
Close
,
Sumanta Pal Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California

Search for other papers by Sumanta Pal in
Google Scholar
PubMed
Close
,
Neeraj Agarwal Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah

Search for other papers by Neeraj Agarwal in
Google Scholar
PubMed
Close
,
Robert A Figlin Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Robert A Figlin in
Google Scholar
PubMed
Close
,
Edwin M Posadas Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Edwin M Posadas in
Google Scholar
PubMed
Close
,
Stephen J Freedland Department of Surgery, Cedars-Sinai Cancer, Los Angeles, California

Search for other papers by Stephen J Freedland in
Google Scholar
PubMed
Close
, and
Jun Gong Department of Medicine, Cedars-Sinai Cancer, Los Angeles

Search for other papers by Jun Gong in
Google Scholar
PubMed
Close

. It is an exquisitely androgen-regulated gene associated with prostate cancer ( Bertram et al . 2013 ). The androgen receptor (AR), and associated signaling, is prominent in prostate tissues as an essential determinant of its development and

Free access
Gustavo Ayala Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Gustavo Ayala in
Google Scholar
PubMed
Close
,
Anna Frolov Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA
Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Anna Frolov in
Google Scholar
PubMed
Close
,
Deyali Chatterjee Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Deyali Chatterjee in
Google Scholar
PubMed
Close
,
Dandan He Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Dandan He in
Google Scholar
PubMed
Close
,
Susan Hilsenbeck Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Susan Hilsenbeck in
Google Scholar
PubMed
Close
, and
Michael Ittmann Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA
Department of Pathology and Laboratory Medicine, Dan L. Duncan Cancer Center, Department of Pathology and Immunology, Department of Veterans Affairs, University of Texas Health Sciences Center Medical School, Houston, Texas, USA

Search for other papers by Michael Ittmann in
Google Scholar
PubMed
Close

Introduction Prostate cancer remains the most common malignancy affecting men, and the second leading cause of cancer-related death of men in the USA. It is a heterogeneous disease, and the biology of various subtypes is still poorly understood. The

Free access
Rhonda L Bitting Divisions of Medical Oncology and Urology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, North Carolina 27710, USA

Search for other papers by Rhonda L Bitting in
Google Scholar
PubMed
Close
and
Andrew J Armstrong Divisions of Medical Oncology and Urology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, North Carolina 27710, USA

Search for other papers by Andrew J Armstrong in
Google Scholar
PubMed
Close

Introduction Prostate cancer is the second most common cancer and sixth leading cause of cancer-related mortality in men, accounting for 903 500 new diagnoses and 258 400 deaths per year worldwide ( Jemal et al . 2011 ). Although the

Free access
Lei Zhang
Search for other papers by Lei Zhang in
Google Scholar
PubMed
Close
and
Gregory J Barritt
Search for other papers by Gregory J Barritt in
Google Scholar
PubMed
Close

, Montell 2005 , Nilius et al. 2005 ). TRPM8 was discovered as a protein that is upregulated in prostate and in some other types of cancer cells ( Tsavaler et al. 2001 ). However, TRPM8 is also expressed in sensory neurons ( McKemy et al. 2002

Free access
Douglas W Strand Department of Urology, Department of Molecular and Medical Pharmacology, University of Texas Southwestern, Dallas, Texas, USA

Search for other papers by Douglas W Strand in
Google Scholar
PubMed
Close
and
Andrew S Goldstein Department of Urology, Department of Molecular and Medical Pharmacology, University of Texas Southwestern, Dallas, Texas, USA

Search for other papers by Andrew S Goldstein in
Google Scholar
PubMed
Close

luminal cells but also as cells of origin for prostate tumors ( Fig. 1 ), which may relate to the genotypic heterogeneity in prostate cancer. We suggest that a deeper understanding of the mechanisms that govern cell fate decisions in prostate development

Free access